Literature DB >> 1573400

The distribution of cathepsin D activity in adult and aging human brain regions.

M Banay-Schwartz1, T DeGuzman, A Kenessey, M Palkovits, A Lajtha.   

Abstract

We measured the activity of cathepsin D, the major cerebral protease, in 50 separate areas of the central nervous system of adult and aged humans, using hemoglobin as the substrate. The activity showed significant regional heterogeneity, with average differences of 50-100% between the lower and higher level areas, and a more than threefold difference between the lowest and highest levels. The forebrain, midbrain, and hindbrain each had areas of high and low activity; cerebellum and cord areas were among those with low activity. Cathepsin levels tended to increase with age in about half of the areas analyzed, and the increases were significant in 14. Statistically significant decreases with aging were observed in two areas. The increases varied between 30 and 60%, and the decreases were 20%. Enzyme activity in thalamus, hypothalamus, pons, medulla, and cerebellum increased with age. In the ventrolateral medulla, which contains the major portion of the cerebral noradrenergic cells, the cathepsin D levels increased with age; in the dorsal raphe area, which contains the major portion of the cerebral serotonergic cells, the enzyme levels decreased. The change with age in human brain seems to be less than what we observed in rat brain, where activity more than doubled in most areas. The changes in enzyme levels need to be tested at more ages to establish a pattern of changes in activity throughout life.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573400     DOI: 10.1111/j.1471-4159.1992.tb10965.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  An immunohistochemical study on cathepsin D in human hippocampus.

Authors:  M Nogami; A Takatsu; N Endo; I Ishiyama
Journal:  Histochem J       Date:  2000-08

2.  Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.

Authors:  Kishore Viswanathan; Dennis J Hoover; Jeannie Hwang; Meagan L Wisniewski; Uzoma S Ikonne; Ben A Bahr; Dennis L Wright
Journal:  ACS Med Chem Lett       Date:  2012-09-09       Impact factor: 4.345

3.  Calpain activity in adult and aged human brain regions.

Authors:  M Banay-Schwartz; T DeGuzman; M Palkovits; A Lajtha
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

4.  Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.

Authors:  Clarissa Valdez; Yvette C Wong; Michael Schwake; Guojun Bu; Zbigniew K Wszolek; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

5.  Cathepsin F is a potential marker for senescent human skin fibroblasts and keratinocytes associated with skin aging.

Authors:  Kento Takaya; Toru Asou; Kazuo Kishi
Journal:  Geroscience       Date:  2022-09-03       Impact factor: 7.581

Review 6.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

7.  Alteration of protease levels in different brain areas of suicide victims.

Authors:  M Banay-Schwartz; T DeGuzman; G Faludi; A Lajtha; M Palkovits
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

8.  Changes in Cathepsin D and Beclin-1 mRNA and protein expression by the excitotoxin quinolinic acid in human astrocytes and neurons.

Authors:  Nady Braidy; Bruce J Brew; Nibaldo C Inestrosa; Roger Chung; Perminder Sachdev; Gilles J Guillemin
Journal:  Metab Brain Dis       Date:  2014-05-16       Impact factor: 3.584

9.  Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models.

Authors:  David Butler; Jeannie Hwang; Candice Estick; Akiko Nishiyama; Saranya Santhosh Kumar; Clive Baveghems; Hollie B Young-Oxendine; Meagan L Wisniewski; Ana Charalambides; Ben A Bahr
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

10.  Myocardial cathepsin D is downregulated in sudden cardiac death.

Authors:  Yu Kakimoto; Ayumi Sasaki; Maki Niioka; Noboru Kawabe; Motoki Osawa
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.